Self-assessment Q&A in Clinical Laboratory Science, III

1. Mass spectrometry 2. Kidney markers 3. Cancer markers 4. Pregnancy 5. Heavy metals and ICP-MS 6. Protein electrophoresis 7. Sepsis 8. Molecular diagnostics for infectious diseases 9. Clinical and forensic toxicology 10. Point-of-care testing 11. Point-of-care technology 12. Cardiac markers 13. Multiple myeloma 14. Liquid biopsy 15. Pharmacogenomics 16. Pharmacokinetics and pharmacodynamics 17. Reference ranges 18. Regulations 19. Hemolysis 20. Icterus 21. Lipemia 22. Pre-analytical variables 23. Bioinformatics 24. Therapeutic drug monitoring 25. Lab automation 26. Transplant TDM 27. Newborn screening 28. Lab statistics 29. Pediatric clinical chemistry 30. Hematology 31. Immunology 32. Autoimmune 33. Novel cardiovascular biomarkers 34. Antimicrobial resistance testing 35. Biomarkers of neurologic diseases 36. HLA testing

Dr. Alan Wu is a Professor of Laboratory Medicine at the University of California at San Francisco. He is the Co-Director of the Core Laboratory at the Zuckerberg San Francisco General Hospital. His research is focused on biomarkers of cardiovascular disease, clinical toxicology, and pharmacogenomics. In this capacity, his clinical and research laboratory conducts testing for routine analytes in blood, urine and cerebral spinal fluid for electrolytes, metabolites, hormones, proteins, and biomarkers. His particular area of interest is in cardiac biomarkers for acute cardiac diseases. He received a B.S. in both Chemistry and Biology at Purdue University and a Ph.D. in Analytical Chemistry at the University of Illinois. He was a professor at the University of Texas and the University of Connecticut prior to his current position at UCSF.